Brand-Ad-30-6
 IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 5232 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
  
 Resource links
   Similar in PUBMED
   Article in PDF (283 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   References

 Article Access Statistics
    Viewed293    
    Printed6    
    Emailed0    
    PDF Downloaded58    
    Comments [Add]    

Recommend this journal

 


 
 Table of Contents    
ERRATUM
Year : 2020  |  Volume : 86  |  Issue : 5  |  Page : 608

Erratum: Future therapies in melasma: What lies ahead?



Date of Web Publication19-Aug-2020

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0378-6323.292501

Rights and Permissions



How to cite this article:
. Erratum: Future therapies in melasma: What lies ahead?. Indian J Dermatol Venereol Leprol 2020;86:608

How to cite this URL:
. Erratum: Future therapies in melasma: What lies ahead?. Indian J Dermatol Venereol Leprol [serial online] 2020 [cited 2020 Oct 27];86:608. Available from: https://www.ijdvl.com/text.asp?2020/86/5/608/292501


In the article titled “Future therapies in melasma: What lies ahead?”, published in pages 8-17, issue 1, vol. 86 of Indian Journal of Dermatology, Venereology and Leprology[1], there are figure citations and legend mismatches:

  • Fig 2: Legend -Drugs targeting hyperactive melanocytes, to be cited after 'Newer agents targeting hyperactive melanocytes' (Pg.9); (Current Fig. 2 citation- to be removed)
  • Fig 4- Legend 'Drugs targeting melanosome transfer to keratinocytes. To be cited after the subheading: 'Newer agents targeting melanosomal transfer' (Pg.11)
  • [Figure 5]: Legend 'Role of a defective skin barrier in melasma'; [Figure 4] cited currently on page 11 to be cited as [figure 5]. (Current Fig 5 citation – to be removed)
  • [Figure 6]: Legend 'Role of Endocrine factors in melasma'. [Figure 6] to be cited on page 12 after 'Newer agents targeting hormones' (Current fig 6 citation in the conclusion – to be removed)


 
  References Top

1.
Sarkar R, Bansal A, Ailawadi P. Future therapies in melasma: What lies ahead? Indian J Dermatol Venereol Leprol 2020;86:8-17.  Back to cited text no. 1
[PUBMED]  [Full text]  




 

Top
Print this article  Email this article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow